JT Toppin had 31 points, eight of them in overtime, and pulled down 13 rebounds to lead No. 16 Texas Tech to a 78-75 win over No. 1 Arizona on Saturday at Tucson, Ariz.
The Seahawks ended the season like they played most of it — dominating on defense. They claimed the top spot in the season's ...
Arizona remains the unanimous No. 1 in the AP Top 25 men's college basketball poll. Michigan jumped to second place after wins over Nebraska and Michigan State.
At Anthropic—an AI lab building some of the world’s most advanced models—engineers are no longer writing the code that powers their products; they’re outsourcing it to AI. The head of Anthropic’s ...
Claude Code generates computer code when people type prompts, so those with no coding experience can create their own programs and apps. By Natallie Rocha Reporting from San Francisco Claude Code, an ...
Right now, you can get nearly half off (47% off) Skullcandy Crusher Evo Headphones. We haven’t tested these sleek over-ear headphones, but they look nice and likely have solid performance. They come ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Harald Nachtmann / Getty Images Rising ...
New players who sign up for the bet365 bonus code offer will unlock one of the most player-friendly welcome offers in the industry. With just a $5 wager, players will receive $200 in bonus bets ― win ...
Onchain data from Nansen showed Solana, BNB Chain, Base, Tron and NEAR handled the most transactions in 2025, as users looked for high‑throughput, low‑fee networks. Onchain analytics firm Nansen ...
Gepotidacin, a new oral antibiotic class, was approved for uncomplicated UTIs, showing noninferiority to nitrofurantoin in phase 3 trials. Semaglutide's indications expanded to include cardiovascular ...
Add Yahoo as a preferred source to see more of our stories on Google. There was some big snake news in 2025. Taylor Stanberry, a Naples native, was the 2025 Florida Python Challenge winner and the ...
William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage biotechs in the bunch. The analysts’ selections for the upcoming year span ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results